EdgarLookup

COSTAR GROUP, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that COSTAR GROUP, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
2.8%
Profit Margin
Net income ÷ revenue
0.1%
Return on Assets
Net income ÷ assets
0.26x
Debt-to-Equity
Total liabilities ÷ equity
+2.6%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $253.99M Feb 23, 2018
FY2017 Sep 30, 2017 $247.53M Feb 23, 2018
FY2017 Jun 30, 2017 $237.15M Feb 23, 2018
FY2017 Mar 31, 2017 $226.55M Feb 23, 2018
FY2017 Dec 31, 2016 $218.31M Feb 23, 2018
FY2017 Sep 30, 2016 $212.71M Feb 23, 2018
FY2017 Jun 30, 2016 $206.87M Feb 23, 2018
FY2017 Mar 31, 2016 $199.74M Feb 23, 2018
FY2017 Dec 31, 2015 $711.76M Feb 23, 2018
FY2016 Dec 31, 2014 $575.94M Feb 24, 2017

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.25B Feb 26, 2026
FY2025 Dec 31, 2024 $2.74B Feb 26, 2026
FY2025 Dec 31, 2023 $2.46B Feb 26, 2026
FY2024 Dec 31, 2022 $2.18B Feb 20, 2025
FY2023 Dec 31, 2021 $1.94B Feb 22, 2024
FY2020 Dec 31, 2020 $444.39M Feb 24, 2021
FY2020 Sep 30, 2020 $425.62M Feb 24, 2021
FY2020 Jun 30, 2020 $397.16M Feb 24, 2021
FY2020 Mar 31, 2020 $391.85M Feb 24, 2021
FY2020 Dec 31, 2019 $374.73M Feb 24, 2021

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.56B Feb 26, 2026
FY2025 Dec 31, 2024 $2.18B Feb 26, 2026
FY2025 Dec 31, 2023 $1.96B Feb 26, 2026
FY2024 Dec 31, 2022 $1.77B Feb 20, 2025
FY2023 Dec 31, 2021 $1.59B Feb 22, 2024
FY2020 Dec 31, 2020 $366.24M Feb 24, 2021
FY2020 Sep 30, 2020 $347.76M Feb 24, 2021
FY2020 Jun 30, 2020 $323.12M Feb 24, 2021
FY2020 Mar 31, 2020 $312.94M Feb 24, 2021
FY2020 Dec 31, 2019 $299.73M Feb 24, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.00M Feb 26, 2026
FY2025 Dec 31, 2024 $139.00M Feb 26, 2026
FY2025 Dec 31, 2023 $375.00M Feb 26, 2026
FY2024 Dec 31, 2022 $369.50M Feb 20, 2025
FY2023 Dec 31, 2021 $292.60M Feb 22, 2024
FY2020 Dec 31, 2020 $35.79M Feb 24, 2021
FY2020 Sep 30, 2020 $58.19M Feb 24, 2021
FY2020 Jun 30, 2020 $60.36M Feb 24, 2021
FY2020 Mar 31, 2020 $72.79M Feb 24, 2021
FY2020 Dec 31, 2019 $87.93M Feb 24, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($72.00M) Feb 26, 2026
FY2025 Dec 31, 2024 $5.00M Feb 26, 2026
FY2025 Dec 31, 2023 $282.00M Feb 26, 2026
FY2024 Dec 31, 2022 $451.00M Feb 20, 2025
FY2023 Dec 31, 2021 $432.30M Feb 22, 2024
FY2020 Dec 31, 2020 $55.21M Feb 24, 2021
FY2020 Sep 30, 2020 $76.81M Feb 24, 2021
FY2020 Jun 30, 2020 $81.32M Feb 24, 2021
FY2020 Mar 31, 2020 $75.86M Feb 24, 2021
FY2020 Dec 31, 2019 $100.99M Feb 24, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $430.00M Feb 26, 2026
FY2025 Dec 31, 2024 $393.00M Feb 26, 2026
FY2025 Dec 31, 2023 $490.00M Feb 26, 2026
FY2024 Dec 31, 2022 $478.70M Feb 20, 2025
FY2023 Dec 31, 2021 $469.70M Feb 22, 2024
FY2022 Dec 31, 2020 $486.11M Feb 22, 2023
FY2021 Dec 31, 2019 $457.78M Feb 23, 2022
FY2020 Dec 31, 2018 $335.46M Feb 24, 2021
FY2019 Dec 31, 2017 $234.70M Feb 26, 2020
FY2018 Dec 31, 2016 $200.64M Feb 28, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $307.00M Feb 26, 2026
FY2025 Dec 31, 2024 $579.00M Feb 26, 2026
FY2025 Dec 31, 2023 $118.00M Feb 26, 2026
FY2024 Dec 31, 2022 $35.20M Feb 20, 2025
FY2023 Dec 31, 2021 $123.70M Feb 22, 2024
FY2022 Dec 31, 2020 $0 Feb 22, 2023
FY2021 Dec 31, 2019 $0 Feb 23, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.54B Feb 26, 2026
FY2025 Dec 31, 2024 $9.26B Feb 26, 2026
FY2024 Dec 31, 2023 $8.92B Feb 20, 2025
FY2023 Dec 31, 2022 $8.40B Feb 22, 2024
FY2022 Dec 31, 2021 $7.26B Feb 22, 2023
FY2021 Dec 31, 2020 $6.92B Feb 23, 2022
FY2020 Dec 31, 2019 $3.85B Feb 24, 2021
FY2019 Dec 31, 2018 $3.31B Feb 26, 2020
FY2018 Dec 31, 2017 $2.87B Feb 28, 2019
FY2017 Dec 31, 2016 $2.19B Feb 23, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.17B Feb 26, 2026
FY2025 Dec 31, 2024 $1.70B Feb 26, 2026
FY2024 Dec 31, 2023 $1.58B Feb 20, 2025
FY2023 Dec 31, 2022 $1.53B Feb 22, 2024
FY2022 Dec 31, 2021 $1.55B Feb 22, 2023
FY2021 Dec 31, 2020 $1.54B Feb 23, 2022
FY2020 Dec 31, 2019 $448.39M Feb 24, 2021
FY2019 Dec 31, 2018 $291.02M Feb 26, 2020
FY2018 Dec 31, 2017 $222.19M Feb 28, 2019
FY2017 Dec 31, 2016 $530.85M Feb 23, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.33B Feb 26, 2026
FY2025 Dec 31, 2024 $7.55B Feb 26, 2026
FY2024 Dec 31, 2023 $7.34B Feb 20, 2025
FY2024 Dec 31, 2022 $6.87B Feb 20, 2025
FY2024 Dec 31, 2021 $5.71B Feb 20, 2025
FY2023 Dec 31, 2020 $5.38B Feb 22, 2024
FY2022 Dec 31, 2019 $3.41B Feb 22, 2023
FY2021 Dec 31, 2018 $3.02B Feb 23, 2022
FY2020 Dec 31, 2017 $2.65B Feb 24, 2021
FY2019 Dec 31, 2016 $1.65B Feb 26, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.94B Feb 26, 2026
FY2025 Dec 31, 2024 $2.53B Feb 26, 2026
FY2025 Dec 31, 2023 $2.39B Feb 26, 2026
FY2024 Dec 31, 2022 $2.31B Feb 20, 2025
FY2023 Dec 31, 2021 $2.32B Feb 22, 2024
FY2022 Dec 31, 2020 $2.24B Feb 22, 2023
FY2021 Dec 31, 2019 $1.88B Feb 23, 2022
FY2020 Dec 31, 2018 $1.61B Feb 24, 2021
FY2019 Dec 31, 2017 $1.28B Feb 26, 2020
FY2018 Dec 31, 2016 $1.25B Feb 28, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.35B Feb 26, 2026
FY2025 Dec 31, 2024 $2.34B Feb 26, 2026
FY2024 Dec 31, 2023 $2.20B Feb 20, 2025
FY2023 Dec 31, 2022 $1.83B Feb 22, 2024
FY2022 Dec 31, 2021 $1.46B Feb 22, 2023
FY2021 Dec 31, 2020 $1.17B Feb 23, 2022
FY2020 Dec 31, 2019 $940.47M Feb 24, 2021
FY2019 Dec 31, 2018 $613.45M Feb 26, 2020
FY2018 Jan 1, 2018 $375.12M Feb 28, 2019
FY2018 Dec 31, 2017 $320.66M Feb 28, 2019

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.63B Feb 26, 2026
FY2025 Dec 31, 2024 $4.68B Feb 26, 2026
FY2024 Dec 31, 2023 $5.20B Feb 20, 2025
FY2023 Dec 31, 2022 $5.00B Feb 22, 2024
FY2022 Dec 31, 2021 $3.80B Feb 22, 2023
FY2021 Dec 31, 2020 $3.69B Feb 23, 2022
FY2020 Dec 31, 2019 $1.07B Feb 24, 2021
FY2019 Dec 31, 2018 $1.10B Feb 26, 2020
FY2018 Dec 31, 2017 $1.21B Feb 28, 2019
FY2018 Dec 31, 2016 $567.22M Feb 28, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $140.00M Feb 26, 2026
FY2024 Dec 31, 2024 $1.00B Feb 20, 2025
FY2023 Dec 31, 2023 $1.00B Feb 22, 2024
FY2022 Dec 31, 2022 $1.00B Feb 22, 2023
FY2021 Dec 31, 2021 $1.00B Feb 23, 2022
FY2020 Dec 31, 2020 $1.00B Feb 24, 2021
FY2019 Dec 31, 2019 $0 Feb 26, 2020
FY2019 Dec 31, 2018 $0 Feb 26, 2020
FY2018 Dec 31, 2017 $0 Feb 28, 2019
FY2017 Dec 31, 2016 $338.34M Feb 23, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 26, 2026
FY2025 Dec 31, 2024 0 Feb 26, 2026
FY2025 Dec 31, 2023 0 Feb 26, 2026
FY2024 Dec 31, 2022 0 Feb 20, 2025
FY2023 Dec 31, 2021 0 Feb 22, 2024
FY2020 Dec 31, 2020 0 Feb 24, 2021
FY2020 Sep 30, 2020 1 Feb 24, 2021
FY2020 Jun 30, 2020 1 Feb 24, 2021
FY2020 Mar 31, 2020 2 Feb 24, 2021
FY2020 Dec 31, 2019 2 Feb 24, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 26, 2026
FY2025 Dec 31, 2024 0 Feb 26, 2026
FY2025 Dec 31, 2023 0 Feb 26, 2026
FY2024 Dec 31, 2022 0 Feb 20, 2025
FY2023 Dec 31, 2021 0 Feb 22, 2024
FY2020 Dec 31, 2020 0 Feb 24, 2021
FY2020 Sep 30, 2020 1 Feb 24, 2021
FY2020 Jun 30, 2020 1 Feb 24, 2021
FY2020 Mar 31, 2020 1 Feb 24, 2021
FY2020 Dec 31, 2019 2 Feb 24, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 417.90M Feb 26, 2026
FY2025 Dec 31, 2024 409.50M Feb 26, 2026
FY2024 Dec 31, 2023 408.10M Feb 20, 2025
FY2023 Dec 31, 2022 406.70M Feb 22, 2024
FY2022 Dec 31, 2021 394.94M Feb 22, 2023
FY2021 Dec 31, 2020 394.29M Feb 23, 2022
FY2020 Dec 31, 2019 36.67M Feb 24, 2021
FY2019 Dec 31, 2018 36.45M Feb 26, 2020
FY2018 Dec 31, 2017 36.11M Feb 28, 2019
FY2017 Dec 31, 2016 32.51M Feb 23, 2018